Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-09-22
2010-11-23
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S293000
Reexamination Certificate
active
07838530
ABSTRACT:
The invention concerns quinazoline derivatives of Formula (I), wherein each of R1a, R1b, R2, R3and a have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.
REFERENCES:
patent: 4335127 (1982-06-01), Vandenberk et al.
patent: 4921863 (1990-05-01), Sugimoto et al.
patent: 5457105 (1995-10-01), Barker
patent: 5616582 (1997-04-01), Barker
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5770599 (1998-06-01), Gibson
patent: 6297258 (2001-10-01), Wissner et al.
patent: 6562319 (2003-05-01), Mishani et al.
patent: 6972288 (2005-12-01), Himmelsbach et al.
patent: 7049438 (2006-05-01), Hennequin et al.
patent: 7148230 (2006-12-01), Bradbury et al.
patent: 7569577 (2009-08-01), Hennequin et al.
patent: 7625908 (2009-12-01), Bradbury et al.
patent: 7632840 (2009-12-01), Delouvrie et al.
patent: 7659279 (2010-02-01), Hennequin et al.
patent: 7696214 (2010-04-01), Hennequin et al.
patent: 2002/0082270 (2002-06-01), Himmelsbach et al.
patent: 2002/0128553 (2002-09-01), Mishani et al.
patent: 2004/0048880 (2004-03-01), Himmelsbach et al.
patent: 2004/0176361 (2004-09-01), Fujio et al.
patent: 2005/0043336 (2005-02-01), Hennequin et al.
patent: 2005/0054662 (2005-03-01), Hennequin et al.
patent: 2005/0165035 (2005-07-01), Bradbury et al.
patent: 2005/0215574 (2005-09-01), Bradbury et al.
patent: 2006/0211714 (2006-09-01), Hennequin et al.
patent: 2006/0258642 (2006-11-01), Hennequin et al.
patent: 2007/0015743 (2007-01-01), Bradbury et al.
patent: 2007/0032508 (2007-02-01), Bradbury et al.
patent: 2007/0032513 (2007-02-01), Hennequin et al.
patent: 2007/0037837 (2007-02-01), Hennequin et al.
patent: 2007/0043009 (2007-02-01), Hennequin et al.
patent: 2007/0043010 (2007-02-01), Bradbury et al.
patent: 2007/0082921 (2007-04-01), Hennequin et al.
patent: 2007/0088044 (2007-04-01), Hennequin et al.
patent: 2007/0099943 (2007-05-01), Bradbury et al.
patent: 2007/0149546 (2007-06-01), Bradbury et al.
patent: 2007/0232607 (2007-10-01), Bradbury et al.
patent: 2007/0244136 (2007-10-01), Hennequin et al.
patent: 2007/0293490 (2007-12-01), Delouvrie et al.
patent: 2008/0096881 (2008-04-01), Bradbury et al.
patent: 2008/0108613 (2008-05-01), Barlaam et al.
patent: 2008/0234263 (2008-09-01), Hennequin et al.
patent: 2008/0269487 (2008-10-01), Bradbury et al.
patent: 2009/0023759 (2009-01-01), Bradbury
patent: 2009/0029968 (2009-01-01), Bradbury et al.
patent: 2009/0048251 (2009-02-01), Bradbury et al.
patent: 2009/0137615 (2009-05-01), Bradbury
patent: 2009/0221616 (2009-09-01), Bradbury
patent: 2009/0239861 (2009-09-01), Bradbury
patent: 2009/0312343 (2009-12-01), Hennequin et al.
patent: 2010/0029696 (2010-02-01), Bradbury
patent: 10040527 (2002-02-01), None
patent: 0 288 563 (1994-05-01), None
patent: 0 566 226 (1995-11-01), None
patent: 0 837 063 (1998-04-01), None
patent: 1 230 919 (2002-08-01), None
patent: 1 369 418 (2003-12-01), None
patent: WO 88/02365 (1988-04-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/30347 (1996-10-01), None
patent: WO 96/33977 (1996-10-01), None
patent: WO 96/33978 (1996-10-01), None
patent: WO 96/33979 (1996-10-01), None
patent: WO 96/33980 (1996-10-01), None
patent: WO 96/33981 (1996-10-01), None
patent: WO 96/39145 (1996-12-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 97/30034 (1997-08-01), None
patent: WO 97/30035 (1997-08-01), None
patent: WO 97/30044 (1997-08-01), None
patent: WO 97/38983 (1997-10-01), None
patent: WO 97/38994 (1997-10-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 99/06378 (1999-02-01), None
patent: WO 99/35132 (1999-07-01), None
patent: WO 00/09481 (2000-02-01), None
patent: WO 00/18740 (2000-04-01), None
patent: WO 00/24718 (2000-05-01), None
patent: WO 00/44728 (2000-08-01), None
patent: WO 00/55141 (2000-09-01), None
patent: WO 00/55141 (2000-09-01), None
patent: WO 00/56720 (2000-09-01), None
patent: WO 01/07432 (2001-02-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 01/94341 (2001-12-01), None
patent: WO 01/98277 (2001-12-01), None
patent: WO 02/24684 (2002-03-01), None
patent: WO 02/30924 (2002-04-01), None
patent: WO 02/34744 (2002-05-01), None
patent: WO 02/41882 (2002-05-01), None
patent: WO 02/44166 (2002-06-01), None
patent: WO 02/48117 (2002-06-01), None
patent: WO 02/056882 (2002-07-01), None
patent: WO 02/062767 (2002-08-01), None
patent: WO 02/066445 (2002-08-01), None
patent: WO 02/068409 (2002-09-01), None
patent: WO 02/073235 (2002-09-01), None
patent: WO 02/076976 (2002-10-01), None
patent: WO 02/092577 (2002-11-01), None
patent: WO 02/092578 (2002-11-01), None
patent: WO 02/097490 (2002-12-01), None
patent: WO 03/002448 (2003-03-01), None
patent: WO 03/024448 (2003-03-01), None
patent: WO 03/040108 (2003-05-01), None
patent: WO 03/040109 (2003-05-01), None
patent: WO 03/049740 (2003-06-01), None
patent: WO 03/082290 (2003-10-01), None
patent: WO 03/082290 (2003-10-01), None
patent: WO 03/082831 (2003-10-01), None
patent: WO 2004/006846 (2004-01-01), None
patent: WO 2004/006846 (2004-01-01), None
patent: WO 2004/064718 (2004-08-01), None
patent: WO 2004/093880 (2004-11-01), None
patent: WO 2004/096226 (2004-11-01), None
patent: WO 2005/012290 (2005-02-01), None
patent: WO 2005/013998 (2005-02-01), None
patent: WO 2005/026150 (2005-03-01), None
patent: WO 2005/026151 (2005-03-01), None
patent: WO 2005/026152 (2005-03-01), None
patent: WO 2005/026156 (2005-03-01), None
patent: WO 2005/026157 (2005-03-01), None
patent: WO 2005/028469 (2005-03-01), None
patent: WO 2005/028470 (2005-03-01), None
patent: WO 2005/030757 (2005-04-01), None
patent: WO 2005/051923 (2005-06-01), None
patent: WO 2005/075439 (2005-08-01), None
patent: WO 2005/118572 (2005-12-01), None
patent: WO 2006/064196 (2006-06-01), None
patent: WO 2006/090163 (2006-08-01), None
patent: WO 2006/092573 (2006-09-01), None
patent: WO 2006/092574 (2006-09-01), None
patent: WO 2006/117521 (2006-11-01), None
patent: WO 2006/117523 (2006-11-01), None
patent: WO 2007/034143 (2007-03-01), None
patent: WO 2007/034144 (2007-03-01), None
patent: WO 2007/063291 (2007-06-01), None
patent: WO 2007/063293 (2007-06-01), None
Grünwald V. et. al., Review, J. Nat. Can. Inst., vol. 95, No. 12, Jun. 18, 2003, pp. 851-867.
Ballard et al. “Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket” Bioorg Med Chem Lett. 16(6):1633-1637 (2006).
Ballard et al. “5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase” Bioorg Med Chem Lett. 15(19):4226-4229 (2005).
Ballard et al. “Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics” Bioorg Med Chem Lett. 16(18):4908-4912 (2006).
Harris et al. “Facile synthesis of 7-amino anilinoquinazolines via direct amination of the quinazoline core” Tetrahedron letters 46(43): 7381-7384 (2005).
Harris et al. “Selective alkylation of a 6,7-dihydroxyquinazoline” Tetrahedron letters 46(45):7715-7719 (2005).
Hennequin et al. “Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: synthesis and structure-activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors” Bioorg Med Chem Lett. 16(10):2672-2676 (2006).
Stamos et al. “Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor” J. Biol. Chem. 277(48):46265-46272 (2002).
Traxler et al. “Protein tyrosine kinase inhibitors in cancer treatment” Exp. Opin. Ther. Patents 7(6):571-588 (1997).
Traxler e
Barlaam Bernard Christophe
Halsall Christopher Thomas
Hennequin Laurent Francois Andre
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Truong Tamthom N
Wilson James O
LandOfFree
Quinazoline derivatives as antiproliferative agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives as antiproliferative agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives as antiproliferative agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156404